DIAGNOS Announces a Second Contract for Its Cardio Platform with a Multinational Pharmaceutical Company and the Resignation of a Director
BROSSARD, QUEBEC–(Marketwired – Nov. 22, 2017) – DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX VENTURE:ADK)(OTCQB:DGNOF), a leader [...]